Erbb2 DNA Vaccine Combined with Regulatory T Cell Deletion Enhances Antibody Response and Reveals Latent Low-Avidity T Cells: Potential and Limits of Its Therapeutic Efficacy

Simona Rolla, Francesco Ria, Sergio Occhipinti, Gabriele Di Sante, Manuela Iezzi, Michela Spadaro, Chiara Nicolo, Elena Ambrosino, Irene Fiore Merighi, Piero Musiani, Guido Forni, Federica Cavallo*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Web of Science)
Original languageEnglish
Pages (from-to)6124-6132
JournalJournal of Immunology
Issue number11
Publication statusPublished - 1 Jun 2010

Cite this